Pacira BioSciences, Inc. (PCRX)

Pacira BioSciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	147.59	276.77	153.3	104.14	585.58	99.96
Short-Term Investments	98.75	207.84	125.28	184.51	70.83	421.71
Cash & Short-Term Investments	246.33	484.62	278.58	288.65	656.41	521.66
Cash Growth	-45.72%	73.96%	-3.49%	-56.03%	25.83%	78.68%
Accounts Receivable	115.27	113.3	105.56	98.4	96.32	53.05
Other Receivables	0.2	0.5	0.4	0.8	0.1	1.6
Receivables	115.47	113.8	105.96	99.2	96.42	54.65
Inventory	157.68	125.28	104.35	96.06	98.55	64.65
Prepaid Expenses	43.27	20.43	20.4	14.32	14.67	10.67
Other Current Assets	-	1	0.7	0.1	-	-
Total Current Assets	562.75	745.13	509.99	498.33	866.05	651.62
Property, Plant & Equipment	191.65	216.39	234.95	254.39	264.81	211.18
Long-Term Investments	20.27	29.45	32.26	60.18	21.99	109.48
Goodwill	20.32	-	163.24	163.24	145.18	99.55
Other Intangible Assets	382.4	425.97	483.26	540.55	623.97	96.52
Long-Term Deferred Tax Assets	120.19	130.38	144.49	160.31	153.36	106.16
Other Long-Term Assets	-	6.2	6.2	4.2	-	-
Total Assets	1,298	1,554	1,574	1,681	2,075	1,275
Accounts Payable	17.69	19.13	15.7	15.22	10.54	10.43
Accrued Expenses	79.64	69.52	55.72	82.49	118.6	68.78
Current Portion of Long-Term Debt	-	201.78	8.64	33.65	374.7	149.65
Current Portion of Leases	9.75	8.89	8.8	9.12	7.89	7.43
Current Income Taxes Payable	-	-	-	-	0.43	0.11
Other Current Liabilities	-	10.61	8.53	7.3	8.95	16.93
Total Current Liabilities	107.08	309.92	97.38	147.77	521.12	253.33
Long-Term Debt	376.72	383.55	513.8	655.82	674.53	313.03
Long-Term Leases	38.84	44.65	54.81	64.8	71.73	71.03
Other Long-Term Liabilities	43.14	37.06	38.27	37.79	77.57	17.44
Total Liabilities	570.36	775.17	704.26	906.19	1,345	654.83
Common Stock	0.05	0.05	0.05	0.05	0.05	0.04
Additional Paid-In Capital	1,050	1,009	976.63	924.1	942.09	873.2
Retained Earnings	-200.96	-206.36	-106.8	-148.75	-211.9	-253.88
Treasury Stock	-125.54	-25.12	-	-	-	-
Comprehensive Income & Other	4.12	0.34	0.25	-0.38	0.17	0.32
Shareholders' Equity	727.21	778.35	870.13	775.01	730.41	619.69
Total Liabilities & Equity	1,298	1,554	1,574	1,681	2,075	1,275
Total Debt	425.31	638.85	586.04	763.39	1,129	541.13
Net Cash (Debt)	-178.97	-154.24	-307.46	-474.74	-472.44	-19.47
Net Cash Per Share	-3.90	-3.34	-5.92	-10.20	-10.35	-0.45
Filing Date Shares Outstanding	43.02	46.28	46.5	45.95	44.85	43.86
Total Common Shares Outstanding	42.97	46.24	46.48	45.93	44.73	43.64
Working Capital	455.67	435.21	412.61	350.56	344.93	398.3
Book Value Per Share	16.93	16.83	18.72	16.87	16.33	14.20
Tangible Book Value	324.5	352.38	223.63	71.22	-38.74	423.62
Tangible Book Value Per Share	7.55	7.62	4.81	1.55	-0.87	9.71
Machinery	191.93	186.07	141.5	136.46	133.34	89.52
Construction In Progress	11.79	28	105.91	103.23	80.56	71.09
Leasehold Improvements	76.34	86.03	61.83	61.3	59.74	54.43

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q